Celldex Therapeutics CLDX
$27.42 −$0.54 (-1.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 -0.07%
Open$27.01
Prev close$27.96
Day range$26.64 – $28.43
Volume1.72M
Market cap$2.15B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts11
Average target$67.18+145.0% vs. price
- Buy 91%
- Hold 9%
Low $29.00Now $27.42Avg $67.18High $100.00
Recent rating changes
The last 20 actions on file set price targets from $29.00 to $100.00, averaging $65.25.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | CCORF | BUY | $68.00 |
| 9 Nov 2026 | Morgan Stanley | BUY | $61.00 |
| 6 Nov 2026 | Stifel | BUY | $68.00 |
| 6 Nov 2026 | Goldman Sachs | HOLD | $29.00 |
| 6 Nov 2026 | Guggenheim | BUY | $100.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $64.00 |
| 6 Nov 2026 | Barclays | BUY | $53.00 |
| 5 Nov 2026 | Cantor Fitzgerald | BUY | $72.00 |
| 20 Oct 2026 | Morgan Stanley | BUY | $57.00 |
| 15 Oct 2026 | Wells Fargo | BUY | $72.00 |
| 13 Oct 2026 | Cantor Fitzgerald | BUY | $72.00 |
| 5 Oct 2026 | H.C. Wainwright | BUY | $64.00 |
| 3 Oct 2026 | LifeSci Capital | BUY | $64.00 |
| 2 Oct 2026 | H.C. Wainwright | BUY | $64.00 |
| 28 Sep 2026 | LifeSci Capital | BUY | $64.00 |
| 26 Sep 2026 | LifeSci Capital | BUY | $56.00 |
| 23 Sep 2026 | CCORF | BUY | $60.00 |
| 23 Sep 2026 | Wells Fargo | BUY | $72.00 |
| 23 Sep 2026 | Morgan Stanley | BUY | $57.00 |
| 23 Sep 2026 | Leerink Partners | BUY | $88.00 |
No comments yet — be the first to weigh in on CLDX.
Sign in to join the discussion.